Abstract
Background Computer-aided digital chest radiograph (CXR) interpretation can facilitate high-throughput screening for tuberculosis (TB), but its use in population-based screening has been limited. We applied an automated image interpretation algorithm, CAD4TBv5, prospectively in an HIV-endemic area. Methods Participants underwent CXR and, for those with symptoms or lung field abnormality, microbiological assessment of sputum collected at a mobile camp in rural South Africa. CAD4TBv5 scored each CXR on a 0-100 scale in the field. An expert radiologist, blinded to the CAD4TBv5 score and other data, assessed CXRs for 1) lung field abnormality and 2) findings diagnostic of active TB (R+). We estimated the performance of CAD4TBv5 for triaging (identifying lung field abnormality as a criteria for sputum examination) and diagnosis (detection of active TB as defined by microbiologic (M+) or radiologic (R+) gold standards). Findings For triaging, a CAD4TBv5 threshold of 25 identified abnormal lung fields with a sensitivity of 90.3% and specificity of 48.2%. For diagnosis, CAD4TBv5 had less agreement with the microbiological reference standard (M+) used to define definite TB (AUC 0.78) than with the radiological reference standard (R+) used to define probable TB (AUC 0.96). HIV-serostatus did not impact CAD4TB's performance. Interpretation A low CAD4TBv5 threshold was required to achieve acceptable triaging sensitivity. Low specificity at this threshold led to high rates of sputum collection despite normal lung fields. CAD4TBv5 had difficulty identifying microbiologically-confirmed TB cases with subtle radiological features but had excellent agreement with the radiologist in identifying radiologically-defined TB cases. We conclude that computer-aided CXR interpretation can be useful in population-based screening in HIV-endemic settings, but threshold selection should be guided by setting-specific piloting and priorities. CXR interpretation algorithms require refinement for the identification of radiologically-subtle early TB.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://data.ahri.org/index.php/catalog/990
Funding Statement
The community-screening programme 'Vukuzazi' is funded by the Africa Health Research Institute, the Wellcome Trust and the Bill and Melinda Gates Foundation. Additional funders include NIAID/NIH (K08AI118538 to EBW). The funders had no role in study design, data analysis and interpretation, or writing of the report. The mobile CXR unit including the real-time use of the CAD4TBv5 software was leased from Aurum Innova in partnership with Delft. The retrospective calculation of CAD4TBv6 scores was provided by Delft free of charge. Delft provided no funding and had no other role in this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics approval was obtained from the University of KwaZulu-Natal Biomedical Research Ethics Committee (BE560/17), the London School of Hygiene & Tropical Medicine Ethics Committee (14722), and the Partners Institutional Review Board (2018P001802).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The Vukuzazi screening protocol and anonymized data can be requested at https://data.ahri.org/index.php/catalog/990.